{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:03:46Z","timestamp":1772183026889,"version":"3.50.1"},"reference-count":55,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T00:00:00Z","timestamp":1545004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Reviews in Medical Virology"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Human cytomegalovirus (CMV) represents the most common infection among recipients of solid organ transplants (SOTs). Previous meta\u2010analysis showed 0.8% of SOT recipients developed CMV disease whilst receiving valganciclovir (ValGCV) prophylaxis. However, the clinical utility of monitoring ganciclovir (GCV) blood concentrations is unclear. We systematically reviewed the association between GCV concentrations during prophylaxis and the incidence of CMV. MEDLINE and EMBASE databases were searched for studies between 1946 and 2018, where GCV pharmacokinetics and incidence of CMV viraemia or disease in SOT were available. Research designs included randomised trials, comparative, prospective cohort, retrospective, or case report studies. Only human adult studies were included, with English language restriction. The 11 studies that met the eligibility criteria included 610 participants receiving GCV or ValGCV prophylaxis. Quality assessment showed 2\/4 randomised trials, 4\/6 cohort studies, and 1\/1 case report were of high quality. Despite dose adjustments for renal impairment, mean GCV exposures for patients were heterogeneous and ranged between 28 and 53.7\u00a0\u03bcg\u00b7h\/mL across three randomised trials. The incidence of CMV infection and disease ranged from 0% to 50% and 0% to 3.1%, respectively, with follow up between 3 to 9\u00a0months. One study showed statistical power in determining relationship, where GCV exposure at 40 to 50\u00a0\u03bcg\u00b7h\/mL in high\u2010risk SOT recipients was associated with a reduced risk of viraemia. Clinical monitoring for GCV exposure can be applied to high\u2010risk SOT recipients during ValGCV prophylaxis; however, further studies are needed to determine the utility of monitoring in all SOT recipients.<\/jats:p>","DOI":"10.1002\/rmv.2023","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T11:23:15Z","timestamp":1545045795000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Systematic review of ganciclovir pharmacodynamics during the prevention of cytomegalovirus infection in adult solid organ transplant recipients"],"prefix":"10.1002","volume":"29","author":[{"given":"Diana D.","family":"Wong","sequence":"first","affiliation":[{"name":"Serology and Virology Division NSW Health Pathology, Prince of Wales Hospital  Sydney New South Wales Australia"},{"name":"School of Medical Sciences, Faculty of Medicine University of New South Wales Sydney  Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy J.","family":"van Zuylen","sequence":"additional","affiliation":[{"name":"Serology and Virology Division NSW Health Pathology, Prince of Wales Hospital  Sydney New South Wales Australia"},{"name":"School of Medical Sciences, Faculty of Medicine University of New South Wales Sydney  Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6004-576X","authenticated-orcid":false,"given":"Maria E.","family":"Craig","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead Institute of Endocrinology and Diabetes  Sydney New South Wales Australia"},{"name":"School of Women's and Children's Health University of New South Wales  Sydney New South Wales Australia"},{"name":"Discipline of Child and Adolescent Health University of Sydney  New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9238-0546","authenticated-orcid":false,"given":"William D.","family":"Rawlinson","sequence":"additional","affiliation":[{"name":"Serology and Virology Division NSW Health Pathology, Prince of Wales Hospital  Sydney New South Wales Australia"},{"name":"School of Medical Sciences, Faculty of Medicine University of New South Wales Sydney  Sydney New South Wales Australia"},{"name":"School of Women's and Children's Health University of New South Wales  Sydney New South Wales Australia"},{"name":"School of Biotechnology and Biomolecular Sciences University of New South Wales Sydney  Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.Supplement_7.S754"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14208"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66553-1"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra064928"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04087.x"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)80021-6"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03420240075030"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/45.suppl_4.29"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905133401903"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002191"},{"key":"e_1_2_9_12_1","unstructured":"Product Monograph Valcyte\u00ae Hoffmann\u2010La Roche Ltd.2017.http:\/\/www.rochecanada.com\/content\/dam\/roche_canada\/en_CA\/documents\/Research\/ClinicalTrialsForms\/Products\/ConsumerInformation\/MonographsandPublicAdvisories\/Valcyte\/Valcyte_PM_E.pdf. Accessed May 17 2017."},{"key":"e_1_2_9_13_1","unstructured":"Product Monograph Cytovene\u00ae Hoffmann\u2010La Roche Ltd.2017.http:\/\/www.rochecanada.com\/content\/dam\/roche_canada\/en_CA\/documents\/Research\/ClinicalTrialsForms\/Products\/ConsumerInformation\/MonographsandPublicAdvisories\/Cytovene\/Cytovene_PM_E.pdf. Accessed September 8 2017."},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2811-2815.2000"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.12.038"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02369.x"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02607-6"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00009-10"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20471"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-012-0293-y"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/10.Supplement_3.S507"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199810270-00023"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00375-13"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01816-13"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12317"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02953-14"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000164512.99703.AD"},{"issue":"2","key":"e_1_2_9_29_1","article-title":"Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+\/R\u2010 transplant recipients","volume":"10","author":"Perrottet N","year":"2009","journal-title":"BMC Infect Dis"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"e_1_2_9_31_1","unstructured":"WellsG SheaB O'ConnellD.et al..The Newcastle\u2010Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta\u2010analyses.2014.http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed July 17 2017."},{"key":"e_1_2_9_32_1","unstructured":"The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews. Checklist for case reports.2016.https:\/\/joannabriggs.org\/assets\/docs\/critical\u2010appraisal\u2010tools\/JBI_Critical_Appraisal\u2010Checklist_for_Case_Reports2017.pdfAccessed September 29 2017."},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182000042"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2011.11.016"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02130-15"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200002150-00014"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00836-08"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2009.01205.x"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2010.00491.x"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.7.2782-2783.2004"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00382.x"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(99)00161-2"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200207270-00014"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03074.x"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2011.12.014"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05535-9"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(95)00381-9"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2007.01.045"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(97)00666-X"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31829df29d"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181cee42f"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02220.x"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.688-692.2000"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200948060-00006"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200402000-00014"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00085-09"}],"container-title":["Reviews in Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frmv.2023","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rmv.2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T04:17:48Z","timestamp":1694492268000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/rmv.2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,17]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1002\/rmv.2023"],"URL":"https:\/\/doi.org\/10.1002\/rmv.2023","archive":["Portico"],"relation":{},"ISSN":["1052-9276","1099-1654"],"issn-type":[{"value":"1052-9276","type":"print"},{"value":"1099-1654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,17]]},"assertion":[{"value":"2018-09-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2023"}}